Failure of oral thiomalate to act as an alternative to intramuscular gold in rheumatoid arthritis.
Ten patients with active rheumatoid arthritis (RA) were entered into a pilot study to evaluate the effectiveness of thiomalic acid as a disease modifying agent and to assess its toxicity. Oral thiomalic acid (100 mg) was given daily for up to six months. Changes in disease activity were recorded mon...
Salvato in:
| Pubblicato in: | Ann Rheum Dis |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMJ Publishing Group
1988
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1003488/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2965555/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.47.3.224 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|